Cut antibiotic use—but not because of resistance Study of C. difficile toxins may lead to new therapiesU.S. researchers have discovered how cells in the gut neutralize toxins produced by Clostridium difficile (C. difficile), a finding that may eventually lead to new methods of treatment. Incivek: second protease inhibitor approved for chronic hepatitis C Drug’s marketing date in Canada has not yet been announced. European agency limits H1N1 vaccine use in kids Canadian study may shed more light on suspected link with narcolepsy Sepsis education doesn’t translate into optimal care Emergency physicians doubt guidelines will save lives Victrelis for chronic hepatitis C launched Drug is used in combination with peginterferon alpha/ribavirin. Fever in returning traveller: new CATMAT guidelines Fever in a returning international traveller should initially be considered a medical emergency, say guidelines. The Birds and the Bees and STIs Preventing and managing common sexually transmitted infections. Scientists discover first gonorrhea strain resistant to all antibiotics Strain poses potential threat to public health worldwide, infectious disease experts say. Zostavax now approved for adults 50 and older to prevent shingles Vaccine was originally indicated only for adults 60 years of age and older. First Previous 117 118 119 120 121 Next Last
